Internal Medicine, Cardiovascular Disease · Memphis, TN
NPI
1477585768
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
6799 Great Oaks Rd, Suite 100
Memphis, TN, 38138
Phone (901) 747-3330
Groups this clinician bills Medicare through
Medicare paid, 2024
$440K
10,668 services
Medicare patients, 2024
913
Average age 77
Drug cost, 2024
$605K
13,919 prescriptions
Company payments, 2025
$630
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David H Iansmith was code 99231 (hospital e&m - subsequent), 1,660 times for 243 patients. In total David H Iansmith billed 10,668 services in 106 codes, and Medicare paid $440K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99231 Hospital E&M - Subsequent | Facility | 1,660 | 243 | $35.78 | $59K |
| 99214 Office E&M - Established | Office | 1,334 | 718 | $78.24 | $104K |
| 93000 Electrocardiogram | Office | 798 | 458 | $8.72 | $6,955 |
| 93288 External Electrocardiographic Monitoring | Office | 551 | 246 | $33.99 | $19K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 393 | 97 | $4.83 | $1,899 |
| 36415 Venipuncture Blood Collection | Office | 323 | 271 | $8.62 | $2,785 |
| 80053 Clinical Chemistry | Office | 315 | 277 | $10.32 | $3,250 |
| 84443 Clinical Chemistry | Office | 306 | 271 | $16.41 | $5,020 |
| 85025 Blood Count | Office | 302 | 267 | $7.61 | $2,298 |
| 80061 Clinical Chemistry | Office | 300 | 264 | $13.03 | $3,910 |
| 82550 Clinical Chemistry | Office | 296 | 261 | $6.34 | $1,876 |
| 85652 Clinical Chemistry | Office | 292 | 260 | $2.63 | $769 |
| 99232 Hospital E&M - Subsequent | Facility | 291 | 181 | $57.00 | $17K |
| 83735 Clinical Chemistry | Office | 284 | 253 | $6.55 | $1,859 |
| 93015 Electrocardiogram | Office | 278 | 262 | $44.24 | $12K |
By year: 2022 $566K for 14,887 services; 2023 $572K for 15,194 services; 2024 $440K for 10,668 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 323 | 271 | $8.62 | $2,785 |
| 80053 Clinical Chemistry | 315 | 277 | $10.32 | $3,250 |
| 84443 Clinical Chemistry | 306 | 271 | $16.41 | $5,020 |
| 85025 Blood Count | 302 | 267 | $7.61 | $2,298 |
| 80061 Clinical Chemistry | 300 | 264 | $13.03 | $3,910 |
| 82550 Clinical Chemistry | 296 | 261 | $6.34 | $1,876 |
| 85652 Clinical Chemistry | 292 | 260 | $2.63 | $769 |
| 83735 Clinical Chemistry | 284 | 253 | $6.55 | $1,859 |
| 83036 Blood Count | 86 | 82 | $9.52 | $819 |
| 81003 Clinical Chemistry | 12 | 11 | $2.20 | $26.4 |
Medicare prescription drug claims, 2024
In 2024, the drug David H Iansmith prescribed most often to Medicare patients was Sotalol (Sotalol Hcl), with 866 prescriptions and refills. In total David H Iansmith wrote 13,919 Medicare prescriptions that cost $605K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sotalol Sotalol Hcl | 866 | 2,169 | 267 | $21K |
| Amlodipine Besylate Generic | 630 | 1,683 | 213 | $4,501 |
| Clopidogrel Clopidogrel Bisulfate | 611 | 1,561 | 201 | $6,259 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 508 | 1,219 | 158 | $9,660 |
| Rosuvastatin Calcium Generic | 478 | 1,298 | 153 | $5,464 |
| Alprazolam Generic | 412 | 413 | 103 | $3,110 |
| Losartan Potassium Generic | 412 | 1,096 | 141 | $4,811 |
| Levothyroxine Sodium Generic | 402 | 1,065 | 131 | $4,012 |
| Clonazepam Generic | 373 | 373 | 87 | $1,607 |
| Potassium Chloride Generic | 341 | 711 | 106 | $4,545 |
| Atorvastatin Calcium Generic | 327 | 907 | 113 | $3,387 |
| Omeprazole Generic | 321 | 865 | 106 | $3,723 |
| Pantoprazole Sodium Generic | 311 | 783 | 103 | $3,912 |
| Simvastatin Generic | 257 | 649 | 70 | $1,758 |
| Furosemide Generic | 257 | 580 | 100 | $1,459 |
Brand drugs: - claims; generic drugs: 12,951 claims; opioid claims: 136.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David H Iansmith $630 ($630 in general payments such as food, travel and fees) from 12 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $120.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $120 |
| Pfizer Inc. PFE | 6 | $113 |
| Actelion Pharmaceuticals US, Inc. JNJ | 6 | $103 |
| Boston Scientific Corporation BSX | 2 | $54.85 |
| Biosense Webster, Inc. JNJ | 1 | $49.82 |
| Amgen Inc. AMGN | 3 | $45.05 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $44.63 |
| Novo Nordisk Inc NVO | 2 | $41.39 |
| Inspire Medical Systems, Inc. INSP | 1 | $20.7 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.